Intuitive Surgical stock tumbled Wednesday after the robotic surgery giant issued a lackluster view for 2026 procedure growth ...

Should you buy stock in Intuitive Surgical right now? Before you buy stock in Intuitive Surgical, consider this: The Motley ...

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

The acquisition aligns with the Intuitive Machines vision, strengthening the Company’s position as a vertically integrated ...

Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.

Intuitive Machines' acquisition of Lanteris and KinetX positions it as a vertically integrated satellite provider. Read why ...

At the 2026 JP Morgan Healthcare event, Intuitive Surgical outlined how its robotic surgical systems continued to grow ...

"Marshall’s rich experience strengthens our board as we move into our next phase of growth," CEO Maggie Nixon said.

Intuitive Machines shares are trading higher Monday. Clear Street maintained a Buy rating and raised the price target to $25.

Intuitive Surgical, Inc. stock: da Vinci robotics leader with 80% share, recurring revenue, fast procedure growth and solid ...

Fourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew ...

Intuitive Surgical (NASDAQ:ISRG) slipped about 5% in Wednesday trading after providing 2026 growth projections for its Da ...